Slavcev Antonij, Rybakova Katerina, Svobodova Eva, Slatinska Janka, Honsova Eva, Skibova Jelena, Viklicky Ondrej, Striz Ilja
Department of Immunogenetics, IKEM, Prague, Czech Republic.
Department of Immunogenetics, IKEM, Prague, Czech Republic.
Transpl Immunol. 2015 Oct;33(2):63-8. doi: 10.1016/j.trim.2015.07.007. Epub 2015 Aug 5.
Our retrospective study included a cohort of 47 patients who underwent living donor kidney transplantation.The pre-transplant frequencies of donor-specific Interferon-gamma (IFN-γ) producing cells were define dusing enzyme-linked immunosorbent spot (ELISpot) assay and correlated with incidence of acute cellular(ACR), antibody-mediated rejection (AMR) and kidney graft survival up to one year after transplantation.
We found a statistically significant correlation between the frequencies of IFN-γ-producing cells and the number of mismatches in HLA antigens between patients and their respective donors – for Class I – A and B (r = 0.399, p b 0.01) and for Class I and Class II antigens – A, B and DR (r = 0.409, p b 0.01). No significant relationship was observed between the numbers of IFN-γ-secreting cells and incidence of acute rejection (neither ACR, nor AMR). However, there was a trend of elevated frequencies of IFN-γ-producing cells in patients who developed ACR or AMR in comparison with kidney recipients free of rejection (91 ± 82 and 114 ± 75 vs. 72 ± 70/5 × 10(4) peripheral blood mononuclear cells respectively). Patients with concurrent acute cellular and antibody-mediated rejection had also higher numbers of IFN-γ-producing memory/effector cells compared to patients with cellular rejection only.
Pre-transplant determination of the numbers of IFN-γ-producing donor-specific memory cells using the ELISpot technique may provide clinically relevant results when evaluating the risk of development of acute cellular and antibody-mediated rejection. These frequencies are influenced by the degree of HLA mismatching between patients and their respective kidney donors.
我们的回顾性研究纳入了一组47例行活体供肾移植的患者。采用酶联免疫斑点(ELISpot)试验确定移植前供体特异性产生γ干扰素(IFN-γ)细胞的频率,并将其与急性细胞性排斥反应(ACR)、抗体介导的排斥反应(AMR)的发生率以及移植后长达一年的肾移植存活率相关联。
我们发现产生IFN-γ细胞的频率与患者及其各自供体之间HLA抗原错配数之间存在统计学显著相关性——对于I类抗原A和B(r = 0.399,p < 0.01)以及对于I类和II类抗原A、B和DR(r = 0.409,p < 0.01)。未观察到分泌IFN-γ细胞的数量与急性排斥反应(ACR和AMR均未观察到)的发生率之间存在显著关系。然而,与未发生排斥反应的肾移植受者相比,发生ACR或AMR的患者中产生IFN-γ细胞的频率有升高趋势(分别为91±82和114±75对72±70/5×10⁴外周血单个核细胞)。与仅发生细胞性排斥反应的患者相比,同时发生急性细胞性和抗体介导排斥反应的患者产生IFN-γ的记忆/效应细胞数量也更高。
在评估急性细胞性和抗体介导排斥反应发生风险时,使用ELISpot技术移植前测定产生IFN-γ的供体特异性记忆细胞数量可能会提供临床相关结果。这些频率受患者与其各自肾供体之间HLA错配程度的影响。